about
Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ RegimenRe-Use of Established Drugs for Anti-Metastatic IndicationsLessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan.Primed for cancer: Li Fraumeni Syndrome and the pre-cancerous nicheRepurposing medicinal compounds for blood cancer treatment.Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27-28 May, 2016, Rosario, ArgentinaRepurposing FDA-approved drugs for anti-aging therapies.Repurposing cephalosporin antibiotics as pro-senescent radiosensitizers.Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, Mumbai.Value added medicines: what value repurposed medicines might bring to society?Clinical response in patients with ovarian cancer treated with metronomic chemotherapy.Low-dose salinomycin induces anti-leukemic responses in AML and MLL.Repurposing itraconazole as an anticancer agent.Repurposing Drugs in Oncology (ReDO)-nitroglycerin as an anti-cancer agent.Anakoinosis: Communicative Reprogramming of Tumor Systems - for Rescuing from Chemorefractory NeoplasiaRepurposing itraconazole for the treatment of cancer.The wisdom of crowds and the repurposing of artesunate as an anticancer drug.Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4.The potential of multi-compound nanoparticles to bypass drug resistance in cancer.Statin use is associated with improved survival in ovarian cancer: A retrospective population-based study.Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents.Repurposed FDA-approved drugs targeting genes influencing aging can extend lifespan and healthspan in rotifers.Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics.Does the oncology community have a rejection bias when it comes to repurposed drugs?Impact of post-diagnostic statin use on ovarian cancer mortality: a systematic review and meta-analysis of observational studies.A bibliometric review of drug repurposing.The Amide Local Anesthetic Lidocaine in Cancer Surgery-Potential Antimetastatic Effects and Preservation of Immune Cell Function? A Narrative Review.Drug Repositioning for Effective Prostate Cancer Treatment.β-Adrenergic receptor modulates mitochondrial metabolism and disease progression in recurrent/metastatic HPV(+) HNSCC
P2860
Q26749972-C833D0B1-3FC5-4FB6-9F6A-691EB94896C9Q26771704-BEDAC7A6-6489-44DE-8140-931CF117CA2BQ34173001-662FC73B-86B8-443B-891B-37C09867E9D7Q35717532-B7744F73-DC1B-4849-B3F8-4B5C9BBE89CEQ35807959-B375DBDF-8A8A-49EE-B798-6E9E719D0A7AQ37239002-1CD36B4A-6700-47A0-BCFD-FA44E32AEE14Q37341939-D6FA3D57-E6C8-46B0-AF5E-3E2D9BBF1B7AQ37376168-119D5599-356E-4FB9-A1A0-334D4F645CDDQ37458763-3C87A085-1303-4227-AEAD-8E71BAEDE0BCQ37669600-973EB9C7-C573-4421-8A69-243432BD8AB4Q37679904-20A2D3E6-3AD4-460E-B4D2-3A12D7C6E0EEQ37687407-D59B19F2-C067-4262-81C4-7F5EF0F12B21Q38633691-F4FD8B60-1C3B-431A-8F0A-EC03580A69C8Q40468319-9C1533C4-7358-448D-8DD0-CCE3A02CEA05Q40640442-9E6B3CA6-DB41-4627-A428-EE379B8F31DEQ41613808-166C0D14-A64F-42AC-804A-1A299EE7E4A7Q41912530-A1F51681-D2D0-4C11-89E2-6949FB53FA38Q46185130-50124EE9-C42D-46D8-99AB-E026DE11D17AQ47114290-E282CDEB-8AF9-4826-9E78-1A8DAE202A29Q47119934-58BEFB07-A135-4535-BDB7-41867061D037Q47162451-9293D9D1-676A-4176-BF67-B6A1EC9D60B0Q48230193-73017D37-4D19-45C0-8C51-B3AC44D3176AQ49315568-40BC4D7B-114C-4CDF-B4EE-ADDC3640038BQ49562067-1F141FDF-2617-45CD-8F96-A5EB0573EA5EQ49884530-0DBE21C1-5B0B-429F-B805-620F461EB6D3Q49907318-65AAC7D3-0567-4761-80DF-0D48C7D0231CQ50059772-CE4C9910-2E3B-4EAF-91E1-A4324C09AFDEQ50074675-B9ACACFF-8769-4D17-82F3-BDB0124FBCDCQ55254671-815CCAFE-78F9-42B1-A659-6D15CDAC3BE9Q57295721-F1431E8B-568A-4822-A10E-FC0667CE0086
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The Repurposing Drugs in Oncology (ReDO) Project.
@ast
The Repurposing Drugs in Oncology (ReDO) Project.
@en
type
label
The Repurposing Drugs in Oncology (ReDO) Project.
@ast
The Repurposing Drugs in Oncology (ReDO) Project.
@en
prefLabel
The Repurposing Drugs in Oncology (ReDO) Project.
@ast
The Repurposing Drugs in Oncology (ReDO) Project.
@en
P2093
P2860
P356
P1476
The Repurposing Drugs in Oncology (ReDO) Project
@en
P2093
Gauthier Bouche
Lydie Meheus
Vidula Sukhatme
Vikas P Sukhatme
P2860
P356
10.3332/ECANCER.2014.442
P577
2014-07-10T00:00:00Z